We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$6.14M
Cap. Flow
-$12.2M
Cap. Flow %
-4.43%
Top 10 Hldgs %
46.48%
Holding
168
New
21
Increased
21
Reduced
21
Closed
18

Top Buys

1
MITA
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
+$9.57M
2
GREE
Greenidge Generation Holdings
GREE
+$6.87M
3
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
+$3.38M
4
CLMT icon
Calumet Specialty Products
CLMT
+$2.85M
5
HZAC
Horizon Acquisition Corporation
HZAC
+$2.09M

Top Sells

1
MITAU
Coliseum Acquisition Corp. Unit
MITAU
+$14.7M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$6.26M
3
FSK icon
FS KKR Capital
FSK
+$4.31M
4
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$3.4M
5
KKR icon
KKR & Co
KKR
+$3.14M

Sector Composition

1 Financials 29.74%
2 Healthcare 23.21%
3 Materials 12.2%
4 Communication Services 7.02%
5 Industrials 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KKR icon
26
KKR & Co
KKR
$90.6B
$3.04M 1.11%
50,000
-50,000
-50% -$3.14M
AVDL
27
DELISTED
Avadel Pharmaceuticals
AVDL
$2.96M 1.07%
301,864
-3,058
-1% -$24.1K
GLHAW
28
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 1.04%
250,000
– –
UTHR icon
29
United Therapeutics
UTHR
$22.7B
$2.82M 1.03%
15,300
– –
JPM icon
30
JPMorgan Chase
JPM
$907B
$2.74M 1%
16,740
-1,430
-8% -$224K
BMY icon
31
Bristol-Myers Squibb
BMY
$124B
$2.51M 0.91%
42,409
-1,000
-2% -$65.9K
AB icon
32
AllianceBernstein
AB
$3.54B
$2.5M 0.91%
50,500
– –
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.19M 0.8%
20,000
-12,000
-38% -$1.25M
HZAC
34
DELISTED
Horizon Acquisition Corporation
HZAC
$2.1M 0.76%
+210,100
New +$2.09M
EIGR
35
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.09M 0.76%
10,416
+864
+9% +$205K
TWLVW
36
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.98M 0.72%
171,666
– –
PMGM
37
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.97M 0.72%
200,000
– –
MSAC
38
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1.95M 0.71%
+200,000
New +$1.93M
INVA icon
39
Innoviva
INVA
$1.6B
$1.93M 0.7%
115,269
+67,471
+141% +$1.01M
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$1.89M 0.69%
124,688
– –
INCY icon
41
Incyte
INCY
$23.4B
$1.82M 0.66%
+26,475
New +$2.01M
FAZE
42
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$1.73M 0.63%
176,963
-350,000
-66% -$3.4M
KAIRW
43
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.69M 0.61%
146,528
– –
TGTX icon
44
TG Therapeutics
TGTX
$8.4B
$1.65M 0.6%
49,592
-781
-2% -$24.2K
CHRS icon
45
Coherus Oncology
CHRS
$216M
$1.65M 0.6%
102,555
+2,900
+3% +$42.5K
QURE icon
46
uniQure
QURE
$2.77B
$1.5M 0.54%
46,766
– –
XENE icon
47
Xenon Pharmaceuticals
XENE
$6.6B
$1.44M 0.52%
94,488
-46,063
-33% -$800K
AUPH icon
48
Aurinia Pharmaceuticals
AUPH
$2.05B
$1.39M 0.51%
62,896
-101,944
-62% -$1.62M
BRIVW
49
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.49%
+116,666
New +$109K
VKTX icon
50
Viking Therapeutics
VKTX
$4.31B
$1.31M 0.47%
208,102
– –
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2021 Portfolio in Review

As of Q3 2021, David M. Knott held 168 positions worth $275M, down 2.2% from $281M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

David M. Knott withdrew a net $12.2M in Q3 2021, closing 18 positions and reducing 21 holdings. Its most notable exit was Coliseum Acquisition Corp. Unit, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Materials.

Against the trend, David M. Knott opened a new position in Coliseum Acquisition Corp. Class A Ordinary Share worth $9.56M.

  • David M. Knott's largest Q3 2021 buy was Coliseum Acquisition Corp. Class A Ordinary Share: 984,835 shares worth $9.56M.
  • David M. Knott added most to Calumet Specialty Products in Q3 2021, an estimated $2.85M increase.
  • David M. Knott's biggest Q3 2021 reduction was FS KKR Capital, cutting an estimated $4.31M.
  • David M. Knott fully exited Coliseum Acquisition Corp. Unit in Q3 2021, selling an estimated $14.7M.
  • David M. Knott's ten largest holdings make up 46% of its $275M portfolio in Q3 2021.
  • David M. Knott opened 21 new positions and closed 18 in Q3 2021.
  • David M. Knott's portfolio value fell 2.2% quarter-over-quarter to $275M.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.